Wealth Effects’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-27,250
Closed -$267K 203
2023
Q1
$267K Sell
27,250
-500
-2% -$5.34K 0.14% 145
2022
Q4
$295K Sell
27,750
-17,500
-39% -$203K 0.17% 133
2022
Q3
$472K Sell
45,250
-1,000
-2% -$13K 0.29% 79
2022
Q2
$582K Buy
46,250
+18,750
+68% +$199K 0.35% 67
2022
Q1
$298K Hold
27,500
0.14% 136
2021
Q4
$387K Buy
+27,500
New +$452K 0.16% 125

Other funds holding DVAX

Wealth Effects's DVAX Position: Q2 2023 in Review

Wealth Effects sold out of Dynavax Technologies (DVAX) in Q2 2023, closing a stake of 27,250 shares — an estimated $267K sold.

Wealth Effects first reported a position in DVAX in Q4 2021 and held it in 6 quarters. The position peaked at $582K in Q2 2022. 215 funds tracked by Wall St. Rank hold DVAX as of Q2 2023.

  • Wealth Effects reported no remaining Dynavax Technologies position as of Q2 2023 after selling out during the quarter.
  • Wealth Effects sold 27,250 Dynavax Technologies shares in Q2 2023, an estimated $267K.
  • Wealth Effects first reported a position in Dynavax Technologies in Q4 2021 and held it in 6 quarters.
  • Wealth Effects's Dynavax Technologies position peaked at $582K in Q2 2022.
  • 215 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2023.

Based on Wealth Effects's 13F filing for Q2 2023, filed 18 Jul 2023.